HKG:1398.HK 25 January 2026

April 17, 2026, 8:31 AM EDT. AxoGen (AXGN) shares jumped 7.5% to $37.37, fueled by strong trading volume and optimism ahead of its first quarter 2026 earnings report due April 28. Analysts expect 20.9% revenue growth year-over-year to $58.7 million and a striking 650% jump in earnings per share to $0.11. Despite this, the consensus earnings per share (EPS) estimate has been revised down by 200% in the past month-an unusual trend given the recent price gains. AxoGen holds a Zacks Rank #3 (Hold) rating. Meanwhile, peer LivaNova (LIVN) declined 0.2%, with a stable EPS outlook but a lower year-over-year change. Investors should monitor if AxoGen's recent surge signifies sustained momentum or a short-term reaction ahead of earnings.